TABLE 2.
General cognition | Memory | Executive function | Attention | Language | Visuospatial | |||||||
Z-score | Z-score | Z-score | Z-Score | Z-score | Z-score | |||||||
Independent |
|
|
|
|
|
|
||||||
variable | β | p | β | p | β | p | β | p | β | p | β | p |
PC 1 | –0.004 | 0.961 | 0.005 | 0.957 | 0.015 | 0.870 | 0.001 | 0.996 | –0.085 | 0.410 | 0.079 | 0.450 |
PC 2 | 0.150 | 0.092 | 0.148 | 0.098 | 0.129 | 0.158 | 0.148 | 0.123 | 0.133 | 0.194 | 0.023 | 0.824 |
PC 3 | 0.325 | <0.001 | 0.418 | <0.001 | 0.276 | 0.004 | 0.256 | 0.003 | 0.266 | 0.011 | 0.041 | 0.700 |
PC 4 | –0.097 | 0.281 | –0.111 | 0.220 | –0.048 | 0.603 | –0.039 | 0.687 | –0.137 | 0.179 | –0.021 | 0.838 |
PC 5 | 0.197 | 0.030 | 0.281 | 0.002 | 0.124 | 0.176 | 0.083 | 0.390 | 0.152 | 0.138 | 0.152 | 0.141 |
PC 6 | –0.126 | 0.159 | –0.022 | 0.809 | –0.128 | 0.163 | –0.180 | 0.029 | –0.042 | 0.682 | –0.115 | 0.269 |
PC 7 | 0.240 | 0.008 | 0.111 | 0.215 | 0.243 | 0.009 | 0.168 | 0.040 | 0.236 | 0.023 | 0.161 | 0.119 |
Disease duration | –0.052 | 0.587 | –0.036 | 0.708 | 0.045 | 0.641 | 0.094 | 0.258 | –0.129 | 0.225 | –0.128 | 0.230 |
MDS-UPDRS-III | –0.312 | 0.001 | –0.202 | 0.031 | –0.358 | <0.001 | –0.020 | 0.004 | –0.186 | 0.073 | –0.315 | 0.003 |
LED | –0.108 | 0.265 | –0.064 | 0.508 | –0.057 | 0.565 | –0.009 | 0.919 | –0.140 | 0.183 | –0.103 | 0.352 |
R2: 0.352 | R2: 0.336 | R2: 0.312 | R2: 0.282 | R2: 0.126 | R2: 0.099 |
PC, Principal component; MDS-UPDRS-III, Movement Disorders Society–Unified Parkinson’s disease Rating Scale III; LED, Levodopa Equivalant Dose. Bold values represent significant contributors to the regression model (p < 0.05).